Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.

Zwiers C, Koelewijn JM, Vermij L, van Sambeeck J, Oepkes D, de Haas M, van der Schoot CE.

Transfusion. 2018 Apr 6. doi: 10.1111/trf.14606. [Epub ahead of print]

PMID:
29624682
2.

Facilitators and barriers for RhD-immunized women to become and remain anti-D donors.

Slootweg YM, Koelewijn JM, de Kort WL, de Haas M, Merz EM.

Transfusion. 2018 Apr;58(4):960-968. doi: 10.1111/trf.14490. Epub 2018 Mar 12.

PMID:
29532485
3.
4.

Better perineal outcomes in sitting birthing position cannot be explained by changing from upright to supine position for performing an episiotomy.

Warmink-Perdijk WDB, Koelewijn JM, de Jonge A, van Diem MT, Lagro-Janssen ALM.

Midwifery. 2016 Mar;34:1-6. doi: 10.1016/j.midw.2016.01.010. Epub 2016 Jan 29.

PMID:
26971440
5.

Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.

Slootweg YM, Koelewijn JM, van Kamp IL, van der Bom JG, Oepkes D, de Haas M.

BJOG. 2016 May;123(6):955-63. doi: 10.1111/1471-0528.13816. Epub 2015 Dec 11.

6.

Haemolytic disease of the fetus and newborn.

de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE.

Vox Sang. 2015 Aug;109(2):99-113. doi: 10.1111/vox.12265. Epub 2015 Apr 20. Review.

PMID:
25899660
7.

Assessing psychological health in midwifery practice: a validation study of the Four-Dimensional Symptom Questionnaire (4DSQ), a Dutch primary care instrument.

Tebbe BB, Terluin B, Koelewijn JM.

Midwifery. 2013 Jun;29(6):608-15. doi: 10.1016/j.midw.2012.05.004. Epub 2012 Aug 9.

PMID:
22882969
8.

Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.

Koelewijn JM, de Haas M, Vrijkotte TG, van der Schoot CE, Bonsel GJ.

BJOG. 2009 Sep;116(10):1307-14. doi: 10.1111/j.1471-0528.2009.02244.x. Epub 2009 Jun 17.

9.

Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy.

Koelewijn JM, Vrijkotte TG, de Haas M, van der Schoot CE, Bonsel GJ.

BJOG. 2009 Apr;116(5):655-64. doi: 10.1111/j.1471-0528.2008.01984.x. Epub 2009 Feb 4.

10.

Women's attitude towards prenatal screening for red blood cell antibodies, other than RhD.

Koelewijn JM, Vrijkotte TG, de Haas M, van der Schoot CE, Bonsel GJ.

BMC Pregnancy Childbirth. 2008 Nov 11;8:49. doi: 10.1186/1471-2393-8-49.

11.

One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.

Koelewijn JM, de Haas M, Vrijkotte TG, Bonsel GJ, van der Schoot CE.

Transfusion. 2008 Aug;48(8):1721-9. doi: 10.1111/j.1537-2995.2008.01742.x. Epub 2008 May 23.

PMID:
18507749
12.

Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.

Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M.

Transfusion. 2008 May;48(5):941-52. doi: 10.1111/j.1537-2995.2007.01625.x. Epub 2008 Feb 1.

PMID:
18248570

Supplemental Content

Loading ...
Support Center